Jan 8 French drugmaker Ipsen SA said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc, including its pancreatic cancer treatment Onivyde, for about $1 billion.
Ipsen will pay $575 million cash at the closing of the deal and up to $450 million more, contingent on some approvals for Onivyde in the United States.
Reuters reported the deal on Sunday, citing people familiar with the matter.
(Reporting by Ismail Shakil in Bengaluru; Editing by Peter Cooney)
Gunman in California UPS shooting targeted co-workers for slayings
June 23 The UPS employee who shot three coworkers to death last week inside a United Parcel Service facility in San Francisco before killing himself appears to have singled out his victims deliberately, but a motive remains unknown, police said on Friday.